ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
批准号:
10788051
负责人:
KEVIN SAUNDERS
金额:
$685.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2026-09-18
关键词:
2019-nCoVAdvanced DevelopmentAnimal ModelClinicalCommunicable DiseasesContractsDisease OutbreaksEmerging Communicable DiseasesFormulationIndividualSARS coronavirusSafetyToxicologyVaccinesefficacy evaluationefficacy testingimmunogenicitymanufacturenovel coronaviruspandemic diseaseresponsestability testingvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
-
批准号:10710595
-
项目类别:
-
资助金额:$1124.82万
-
财政年份:2022
-
负责人:KEVIN SAUNDERS
-
依托单位:
海外基金